Didier Blaise

Research interests

Publications

• Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients

  Bone Marrow Transplantation · 2020 · https://doi.org/10.1038/s41409-020-0803-y

• Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation

  Nature Medicine · 2019 · https://doi.org/10.1038/s41591-019-0400-z

• The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation

  Bone Marrow Transplantation · 2018 · https://doi.org/10.1038/s41409-017-0062-8

• Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT

  Journal of Hematology & Oncology · 2018 · 10.1186/s13045-018-0586-4

• Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation

  Bone Marrow Transplantation · 2016 · https://doi.org/10.1038/bmt.2016.130

• Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia

  Blood · 2015 · https://doi.org/10.1182/blood-2014-09-599894

• Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT)

  Bone Marrow Transplantation · 2015 · https://doi.org/10.1038/bmt.2015.52

• Hematopoietic stem cell transplantation for patients with AML in first complete remission

  Blood · 2015 · 10.1182/blood-2015-07-604546

• Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia

  Leukemia · 2015 · 10.1038/leu.2015.98

• Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

  Transplantation and Cellular Therapy · 2014 · https://doi.org/10.1016/j.bbmt.2014.10.021

• Targeting natural killer cells and natural killer T cells in cancer

  Nature reviews. Immunology · 2012 · https://doi.org/10.1038/nri3174

• Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation

  Leukemia · 2012 · 10.1038/leu.2012.135

• Defining the Intensity of Conditioning Regimens: Working Definitions

  Transplantation and Cellular Therapy · 2009 · https://doi.org/10.1016/j.bbmt.2009.07.004

• Graft-Versus-Lymphoma Effect for Aggressive T-Cell Lymphomas in Adults: A Study by the Société Française de Greffe de Moëlle et de Thérapie Cellulaire

  Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2007.14.1366

• Allogeneic hematopoietic cell transplantation for metastatic breast cancer

  Bone Marrow Transplantation · 2007 · https://doi.org/10.1038/sj.bmt.1705940

• Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)

  Leukemia · 2005 · https://doi.org/10.1038/sj.leu.2403967

• An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation

  Bone Marrow Transplantation · 2003 · 10.1038/sj.bmt.1703891

• Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study

  Blood · 2002 · https://doi.org/10.1182/blood.v100.9.3128

• Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies

  Blood · 2001 · 10.1182/blood.v98.13.3569

• Randomized Trial of Bone Marrow Versus Lenograstim-Primed Blood Cell Allogeneic Transplantation in Patients With Early-Stage Leukemia: A Report From the Société Française de Greffe de Moelle

  Journal of Clinical Oncology · 2000 · 10.1200/jco.2000.18.3.537

• Peripheral Blood Stem Cell and Bone Marrow Transplantation for Solid Tumors and Lymphomas: Hematologic Recovery and Costs: A Randomized, Controlled Trial

  Annals of Internal Medicine · 1997 · 10.7326/0003-4819-126-8-199704150-00002

• Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle.

  Journal of Clinical Oncology · 1994 · 10.1200/jco.1994.12.6.1217

• Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse [see comments]

  Blood · 1992 · 10.1182/blood.v79.10.2578.bloodjournal79102578

• Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse [see comments]

  Blood · 1992 · 10.1182/blood.v79.10.2578.2578

• IMPACT OF T-CELL DEPLETION ON OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR STANDARD-RISK LEUKAEMIAS

  The Lancet · 1987 · 10.1016/s0140-6736(87)90763-x

Current projects

No projects listed.